Research Services Core (RSC)
Research Services Core (RSC)
批准号:
10908198
负责人:
Samuel Michael
金额:
$473.89万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AcousticsAptitudeAstrocytesAugmented RealityAutomationBiologicalBiological AssayBiologyBiomanufacturingBostonCancer BiologyCellsChemical StructureChemicalsClinicalCollaborationsCollectionCommunitiesComplexComputer softwareCountryCustomDana-Farber Cancer InstituteDataData AnalysesDatabasesDevelopmentDevice DesignsDevicesDoseDrug CombinationsEmerging TechnologiesEngineeringEnsureEquipmentEvaluationFeedbackFriendsHospitalsHybridsHypothalamic structureImageIncubatorsInternetIntramural Research ProgramLaboratoriesLibrariesLiquid substanceMaintenanceMeasuresMethodsMissionNational Center for Advancing Translational SciencesNatureNeurobiologyNeuronsNeurosciencesNociceptorsPatientsPeripheralPhaseProcessProtocols documentationRare DiseasesRecording of previous eventsReportingResearchResearch PersonnelResearch SupportReservationsRetrievalRobotRoboticsRunningSamplingScheduleScientistServicesSiteSmall Business Innovation Research GrantSpottingsSystemTechnologyTestingTimeTrainingTubeUniversitiesValidationVial deviceWorkarmassay developmentcell bankdesigndetectorflasksfollow-uphigh throughput screeningimagerimprovedinduced pluripotent stem cellinstrumentinstrumentationmedical schoolsmembernew technologynext generationoperationpreservationresponsescale upscreeningsmall moleculestem cellstissue culturetrophoblastvigilance
中文摘要
点击翻译按钮获取中文摘要
英文摘要
1. Automation
a. Two accepted phase 1 proposals for an Automated Flask Cleaning device design. 2 accepted phase 2 SBIR proposals for Augmented Reality for rare diseases.
b. Instrumentation and Automation scheduling site stats Automation Scheduling had a total of 142 reservations, 185 protocols were run, 80+ total users registered. Instrumentation site had a total of 112 reservations for stand-alone devices (limited to overflow equipment from Outlook but expanding), there were also 133 maintenance requests to report issues on equipment (increasing) with 200+ registered users.
c. 10 complex robotic platforms (ranging from the Primary screening robot to the fully automated BSL-3 system) and at least 250 pieces of regularly used equipment comprised of pintool transfer devices, solenoid valve small volume liquid dispensers, bulk dispensers and washers, acoustic transfer devices, robotic arms, incubators, centrifuges, plate sealers and peelers are maintained by RSC saving hundreds of thousands of dollars.
d. Collaboration with DPI ETB members and Arimation Robotics to help design, build and implement an automation-friendly instrument to measure and collect data for Real Time Cellular Thermal Shift Assay (RT-CETSA). Design and testing phases complete with factory acceptance testing planned for September 2023.
2. Compound Management
a. Automated tube reformatting and acoustic dispensing system designed, built custom for, and guided by NCATS compound management cutting edge needs. A straight from storage tube acoustic dispenser and a complex liquid handling platform was integrated with our compound store along with necessary peripherals for plate prep/preservation and decapping/capping capabilities to fully automated tube picking through assay ready plate creation while eliminating extra intermediate pipetting steps therefore reducing plastic consumables by 1/3 to 1/2 depending on the process. Installation, site acceptance testing, and training complete. Validation in process.
b. Busiest year in history. 2,236 FOTS orders were filled for DPI biology groups and collaborators. Compounds requested 79% internally and 21% externally delivered around the country.
c. 4,612 plates produced (acoustic 40% and non-acoustic 60%) for 771 orders. 65% were for Drug Combination, 27% for follow up plates, and 8% were qHTS style plates. 51% of the acoustic spotted plates were produced on our multiple automated acoustic platforms.
3. Automated Cell Technologies
a. CellTrio System: RoboCell designed, custom built, and guided by NCATS cell technologies cutting edge needs to increase capability as well as scale up from existing Sartorius CompacT SelecT units. Includes flask handling, decappng/capping, detector, confluency inspection/imaging, complex liquid handling and dispensing as well as storage. Factory acceptance testing is ongoing to ensure necessary functionality.
b. Five robotic high throughput biomanufacturing and functional differentiation processes of hiPSCs for Nocicenptors, Astrocytes, Trophoblasts, Hypothalamic neurons as well as adaptation of patient iPSCs in system and clean up. Supports internal (Stem Cell, 3DTBPL, etc) and numerous external collaborators. Involves direct involvement and feedback from scientists on process and evaluation.
c. Nociceptors cell bank generated from 12 iPSC lines into 792 cryovials containing 5M cells/vial = 3.96B Nociceptor cells. Collaborators include Boston Childrens Hospital, Harvard Medical School, Department of Neurobiology, Dana Farber Cancer Institute, Department of Cancer Biology, and Nuffield Department of Clinical Neurosciences, The University of Oxford. Astrocytes cell bank generated from 14 iPSC lines into 392 cryovials containing 0.4M 10M cells/vial = 2.5B Astrocyte cells. Hypothalamic neurons generated from 3 iPSC lines into 91 cryovials containing 5M cells/vial = 455M Hypothalamic neurons.
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1177/2472555220911451
发表时间:
2020-06
期刊:
SLAS discovery : advancing life sciences R & D
影响因子:
--
作者:
[Roth JS, Lee TD, Cheff DM, Gosztyla ML, Asawa RR, Danchik C, Michael S, Simeonov A, Klumpp-Thomas C, Wilson KM, Hall MD]
通讯作者:
Hall MD
Development of an assay pipeline for the discovery of novel small molecule inhibitors of human glutathione peroxidases GPX1 and GPX4.
开发用于发现人谷胱甘肽过氧化物酶GPX1和GPX4的新型小分子抑制剂的测定管道。
DOI:
10.1016/j.redox.2023.102719
发表时间:
2023-07
期刊:
REDOX BIOLOGY
影响因子:
11.4
作者:
[Cheff, Dorian M., Cheng, Qing, Guo, Hui, Travers, Jameson, Klumpp-Thomas, Carleen, Shen, Min, Arner, Elias S. J., Hall, Matthew D.]
通讯作者:
Hall, Matthew D.
DOI:
10.3389/fphar.2022.1040039
发表时间:
2022
期刊:
Frontiers in pharmacology
影响因子:
5.6
作者:
[]
通讯作者:
DOI:
10.1371/journal.pone.0130796
发表时间:
2015
期刊:
PloS one
影响因子:
3.7
作者:
[Lee JA, Shinn P, Jaken S, Oliver S, Willard FS, Heidler S, Peery RB, Oler J, Chu S, Southall N, Dexheimer TS, Smallwood J, Huang R, Guha R, Jadhav A, Cox K, Austin CP, Simeonov A, Sittampalam GS, Husain S, Franklin N, Wild DJ, Yang JJ, Sutherland JJ, Thomas CJ]
通讯作者:
Thomas CJ
DOI:
10.1371/journal.pone.0166318
发表时间:
2016
期刊:
PloS one
影响因子:
3.7
作者:
[Cong Y, Dyall J, Hart BJ, DeWald LE, Johnson JC, Postnikova E, Zhou H, Gross R, Rojas O, Alexander I, Josleyn N, Zhang T, Michelotti J, Janosko K, Glass PJ, Flint M, McMullan LK, Spiropoulou CF, Mierzwa T, Guha R, Shinn P, Michael S, Klumpp-Thomas C, McKnight C, Thomas C, Eakin AE, O'Loughlin KG, Green CE, Catz P, Mirsalis JC, Honko AN, Olinger GG Jr, Bennett RS, Holbrook MR, Hensley LE, Jahrling PB]
通讯作者:
Jahrling PB
共 12 条
Research Services Core (RSC)
-
批准号:10011454
-
项目类别:
-
资助金额:$836.4万
-
财政年份:--
-
负责人:Samuel Michael
-
依托单位:
Research Services Core (RSC)
-
批准号:10682313
-
项目类别:
-
资助金额:$431.23万
-
财政年份:--
-
负责人:Samuel Michael
-
依托单位:
HEAL: New Chemical Structures for Pain, Addiction and Overdose Targets
-
批准号:10259366
-
项目类别:
-
资助金额:$238.92万
-
财政年份:--
-
负责人:Samuel Michael
-
依托单位:
Helping to End Addiction Long-term (HEAL): New Chemical Structures for Pain, Addiction and Overdose Targets
-
批准号:10688949
-
项目类别:
-
资助金额:$518.03万
-
财政年份:--
-
负责人:Samuel Michael
-
依托单位:
Helping to End Addiction Long-term (HEAL): New Chemical Structures for Pain, Addiction and Overdose Targets
-
批准号:10908194
-
项目类别:
-
资助金额:$397.09万
-
财政年份:--
-
负责人:Samuel Michael
-
依托单位:
Research Services Core (RSC)
-
批准号:10261247
-
项目类别:
-
资助金额:$1009.75万
-
财政年份:--
-
负责人:Samuel Michael
-
依托单位:
Development of A Specialized Platform for Innovative Research Exploration (ASPIRE)
-
批准号:10908200
-
项目类别:
-
资助金额:$635.56万
-
财政年份:--
-
负责人:Samuel Michael
-
依托单位:
海外基金